EUVIMEDEUVIMED entdecken
Crossref

GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells

Hanxiao Sun iD, Jie Shu, Jupei Tang, Yue Li, Jinxin Qiu, Zhaoyun Ding, Binbin Xuan, Minghui Chen, Chenxin Gan, Jinpiao Lin, Ju Qiu iD, Huiming Sheng und 1 weitere

Immunology · 2024-07 · 172 (3) · 451-468

DOI: 10.1111/imm.13784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, online erschienen am 27.03.2024. Verfasst von Hanxiao Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Glucagon-Like Peptide-1 Receptor, Immunity, Innate. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Outstanding Academic Leader Science and Technology Program, Changning District Master Doctor Innovative Talent Base.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), which are drugs used for treating type 2 diabetes, have been reported to exert anti‐inflammatory effects on inflammatory bowel disease (IBD), the mechanism of which remains elusive. Here, we report that GLP‐1RAs ameliorate dextran sulfate sodium (DSS)‐induced colitis in both wild‐type and T/B‐cell‐deficient mice through modulating group 3 innate lymphoid cells (ILC3s), a subset of innate lymphoid cells that regulate intestinal immunity. GLP‐1RAs promote IL‐22 production by ILC3, and the protective effect of GLP‐1RAs on DSS‐induced colitis was abrogated in ILC3‐deficient RORgt gfp/gfp mice. Furthermore, the treatment effect of GLP‐RAs on colitis, as well as the generation of IL‐22‐producing ILC3s by GLP‐RAs, is dependent on the gut microbiota. GLP‐1RAs increase the abundance of Firmicutes and Proteobacteria in the gut, particularly beneficial bacteria such as Lactobacillus reuteri, and decrease the abundance of enteropathogenic Staphylococcus bacteria. The untargeted gas chromatography (GC)/liquid chromatography (LC)‐mass spectrometry (MS) of faecal metabolites further revealed enrichment of N,N‐dimethylsphingosine (DMS), an endogenous metabolite derived from sphingosine, in the GLP‐1RA‐treated group. Strikingly, DMS ameliorates colitis while promoting intestinal IL‐22‐producing ILC3s. Taken together, our findings show that GLP‐1RAs exert a therapeutic effect on colitis possibly by regulating the microbiota‐DMS‐IL‐22 + ILC3 axis, highlighting the potential beneficial role of GLP‐RAs in inflammatory intestinal disorders with diabetes complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitisGlucagon-Like Peptide-1 ReceptorImmunity, InnateLymphocytesDextran SulfateInterleukin-22Glucagon-Like Peptide-1 Receptor AgonistsAnimalsMiceMice, Inbred C57BLDisease Models, AnimalInterleukinsMice, KnockoutColonLiraglutide

Stichwörter der Autor:innen

N,N‐dimethylsphingosine (DMS)colitisglucagon‐like peptide 1 receptor agonists (GLP‐1RAs)group 3 innate lymphoid cells (ILC3s)gut microbiome

Substanzen

Glucagon-Like Peptide-1 ReceptorDextran SulfateInterleukin-22InterleukinsLiraglutideGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong, China.
  • Department of Laboratory Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

ORCID-Profile: Hanxiao Sun, Ju Qiu

Förderung

  • National Natural Science Foundation of China
  • Shanghai Outstanding Academic Leader Science and Technology Program
  • Changning District Master Doctor Innovative Talent Base
  • Shanghai Jiao Tong University Key Project of Medical Engineering
  • Project of Changning District Health Commission
  • Youth Project of Changning District Health Commission
  • Firefly Project Plan of Tongren Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
  • Shanghai Science and Technology Committee (STCSM)

Zitieren

APA

Sun, H., Shu, J., Tang, J., Li, Y., Qiu, J., Ding, Z., Xuan, B., Chen, M., Gan, C., Lin, J., Qiu, J., Sheng, H., & Wang, C. (2024). GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells. Immunology, 172(3), 451-468. https://doi.org/10.1111/imm.13784

Vancouver

Sun H, Shu J, Tang J, Li Y, Qiu J, Ding Z, et al. GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells. Immunology. 2024;172(3):451-468. doi:10.1111/imm.13784

BibTeX
@article{Sun2024,
  author = {Sun, Hanxiao and Shu, Jie and Tang, Jupei and Li, Yue and Qiu, Jinxin and Ding, Zhaoyun and Xuan, Binbin and Chen, Minghui and Gan, Chenxin and Lin, Jinpiao and Qiu, Ju and Sheng, Huiming and Wang, Chuanxin},
  title = {GLP ‐1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells},
  journal = {Immunology},
  year = {2024},
  volume = {172},
  number = {3},
  pages = {451--468},
  doi = {10.1111/imm.13784}
}
Kostenlos starten →